Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis

Jasmohan S. Bajaj, K. Rajender Reddy, Puneeta Tandon, Guadalupe Garcia‐Tsao, Patrick S. Kamath, Jacqueline G. O'Leary, Florence Wong, Jennifer Lai, Hugo Vargas, Paul J. Thuluvath, Ram M. Subramanian, Marcela Pena‐Rodriguez, Masoumeh Sikaroodi, Leroy R. Thacker, Patrick M. Gillevet – 29 July 2022 – Cirrhosis is complicated by a high rate of nosocomial infections (NIs), which result in poor outcomes and are challenging to predict using clinical variables alone. Our aim was to determine predictors of NI using admission serum metabolomics and gut microbiota in inpatients with cirrhosis.

Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient‐reported quality of life

Laura Heath, Paul Aveyard, Jeremy W. Tomlinson, Jeremy F. Cobbold, Dimitrios A. Koutoukidis – 27 July 2022 – Nonalcoholic steatohepatitis (NASH) is a prevalent chronic disease that is associated with a spectrum of liver fibrosis and can lead to cirrhosis. Patients with NASH report lower health‐related quality of life (HRQoL) than the general population. It remains uncertain how changes in histologic severity are associated with changes in HRQoL.

Reduction in gut‐derived MUFAs via intestinal stearoyl‐CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma

Simon Ducheix, Elena Piccinin, Claudia Peres, Oihane Garcia‐Irigoyen, Justine Bertrand‐Michel, Allan Fouache, Marica Cariello, Jean‐Marc Lobaccaro, Hervé Guillou, Carlo Sabbà, James M. Ntambi, Antonio Moschetta – 27 July 2022 – Nonalcoholic fatty liver disease (NAFLD) is defined by a set of hepatic conditions ranging from steatosis to steatohepatitis (NASH), characterized by inflammation and fibrosis, eventually predisposing to hepatocellular carcinoma (HCC).

Heterologous adenovirus‐vector/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipients

Manuel Mendizabal, Nicolás Ducasa, Paula Benencio, Margarita Anders, Fernando Cairo, Manuel Barbero, Patricia Etcheves, Adriana Alter, Giampaolo Scarton, Juan G. Abraldes, Mirna Biglione, Ezequiel Mauro – 27 July 2022 – Knowledge of the immunogenicity of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in liver transplant recipients (LTRs) is mainly limited to messenger RNA (mRNA)‐based types.

Inhibition of lysyl oxidase‐like 2 overcomes adhesion‐dependent drug resistance in the collagen‐enriched liver cancer microenvironment

Lanqi Gong, Yu Zhang, Yuma Yang, Qian Yan, Jifeng Ren, Jie Luo, Yuen Chak Tiu, Xiaona Fang, Beilei Liu, Raymond Hiu Wai Lam, Ka‐On Lam, Anne Wing‐Mui Lee, Xin‐Yuan Guan – 26 July 2022 – The tumor microenvironment (TME) is considered to be one of the vital mediators of tumor progression. Extracellular matrix (ECM), infiltrating immune cells, and stromal cells collectively constitute the complex ecosystem with varied biochemical and biophysical properties.

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation

Takahiro Tomiyama, Takuya Yamamoto, Shokichi Takahama, Takeo Toshima, Shinji Itoh, Noboru Harada, Mototsugu Shimokawa, Daisuke Okuzaki, Masaki Mori, Tomoharu Yoshizumi – 26 July 2022 – The quality and size of liver grafts are critical factors that influence living‐donor liver transplantation (LDLT) function and safety. However, the biomarkers used for predicting graft quality are lacking. In this study, we sought to identify unique graft quality markers, aside from donor age, by using the livers of non‐human primates.

Subscribe to